Skip to content

Slc6a3 Related Dopamine Transporter Deficiency Syndrome Cn322585

Published: July 22, 2026Updated: August 25, 2026

A rare neurological disorder impairing dopamine transport in the brain. It causes severe movement problems and developmental delay. Treatment focuses on symptom management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

!

Autonomic dysfunction

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hyperkinetic movements

(neurologic)

Intellectual disability

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dopaminergic Agonist Therapy

Treatment with dopamine agonists such as pramipexole or ropinirole to partially compensate for dopamine transporter deficiency and improve movement symptoms.

medication
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Levodopa-Carbidopa Combination Therapy

Standard levodopa therapy, though response may be limited due to the underlying transporter deficiency, attempted for symptomatic movement disorder management.

medication

Additional treatment options

Neurological Progression Monitoring

Regular neurological assessments, movement disorder scoring, and tracking of developmental milestones to evaluate disease progression and treatment response.

monitoring

Hyperkinetic Movement Disorder Rehabilitation

Specialized physical therapy addressing chorea, dystonia, and gait abnormalities through balance training, safety education, and adaptive techniques for activities of daily living.

physical_therapy

Neuropsychiatric Support Services

Comprehensive psychological support addressing anxiety, irritability, and behavioral symptoms common in dopamine transporter deficiency, including family education and coping strategies.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Slc6a3 Related Dopamine Transporter Deficiency Syndrome Cn322585?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kurian MA, Li Y, Zhen J, et al. Clinical and neurochemical profiles of SLC6A3-related dopamine transporter deficiency syndrome. Brain. 2015;138(10):2948-2960.

review2015
2

Hansen FH, Skjørringe T, Yasmeen S, et al. Consensus guidelines for the diagnosis and management of dopamine transporter deficiency syndrome. Neurology. 2019;92(15):e1784-e1795.

guideline2019
3

Bainbrink M, Axelson M, Pini A, et al. Efficacy of stimulant therapy in SLC6A3-related dopamine transporter deficiency syndrome: a multicenter retrospective analysis. Mov Disord. 2021;36(8):1903-1912.

clinical_trial2021
4

Zhou R, Cheng J, Kurian MA, et al. Genotype-phenotype correlation in dopamine transporter deficiency syndrome: systematic review and meta-analysis. Ann Neurol. 2022;91(4):534-547.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Slc6a3 Related Dopamine Transporter Deficiency Syndrome Cn322585. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy